Role of functional single nucleotide polymorphisms of MMP1, MMP2, and MMP9 in open angle glaucomas

被引:0
|
作者
Mossboeck, Georg [1 ]
Weger, Martin [1 ]
Faschinger, Christoph [1 ]
Zimmermann, Christine [1 ]
Schmut, Otto [1 ]
Renner, Wilfried [2 ]
El-Shabrawi, Yosuf [1 ]
机构
[1] Med Univ Graz, Dept Ophthalmol, A-8036 Graz, Austria
[2] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria
来源
MOLECULAR VISION | 2010年 / 16卷 / 191-92期
关键词
LOXL1 GENE POLYMORPHISMS; MATRIX METALLOPROTEINASES; EXFOLIATION-SYNDROME; EXTRACELLULAR-MATRIX; INTRAOCULAR-PRESSURE; TISSUE INHIBITORS; SEQUENCE VARIANTS; CLOSURE GLAUCOMA; AQUEOUS-HUMOR; ASSOCIATION;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose: Matrix metalloproteinases (MMPs) play an essential role in the turnover of the extracellular matrix and cellular behavior. MMP1, MMP2, and MMP9 have previously been implicated in the pathogenesis of primary open angle glaucoma (POAG) and open angle glaucoma secondary to exfoliation syndrome (XFG), respectively. Functional gene polymorphisms of these MMPs such as MMP1 -1607 1G/2G (rs1799750), MMP2 -1306 C/T (rs243865), MMP2 -1575 G/A (rs243866), and MMP9 Q279R (rs17576) are thus plausible candidates as risk factors for open angle glaucomas. The purpose of the present study was to investigate hypothesized associations between these polymorphisms and the presence of POAG and XFG in a Caucasian population. Methods: The present case-control study included 322 patients with POAG, 202 patients with XFG, and 248 control subjects. Genotyping of polymorphisms was done using polymerase chain reaction. Results: No significant differences in either genotype distributions or allelic frequencies of MMP1 -1607 1G/2G, MMP2 -1306 C/T, MMP2 -1575 G/A, and MMP9 Q279R were found between patients with POAG and control subjects and patients with XFG and control subjects, respectively (p>0.05). The presence of POAG or XFG was not predicted by any of the investigated polymorphisms. Conclusions: Our data suggest that the MMP1 -1607 1G/2G, MMP2 -1306 C/T, MMP2 -1575 G/A, and MMP9 Q279R polymorphisms themselves are unlikely major risk factors among Caucasian patients with either POAG or XFG.
引用
收藏
页码:1764 / 1770
页数:7
相关论文
共 50 条
  • [41] ANALYSIS OF COL1A1 AND MMP9 SINGLE NUCLEOTIDE POLYMORPHISMS IN MANDIBULAR PROGNATHISM
    Milosevic, Olga
    Nikolic, Nadja
    Carkic, Jelena
    Majstorovic, Nemanja
    Glisic, Branislav
    Milasin, Jelena
    GENETIKA-BELGRADE, 2022, 54 (02): : 777 - 786
  • [42] Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model
    Mendes, O
    Kim, HT
    Stoica, G
    CLINICAL & EXPERIMENTAL METASTASIS, 2005, 22 (03) : 237 - 246
  • [43] Expression of MMP2, MMP9 and MMP3 in Breast Cancer Brain Metastasis in a Rat Model
    Odete Mendes
    Hun-Taek Kim
    George Stoica
    Clinical & Experimental Metastasis, 2005, 22 : 237 - 246
  • [44] Gelatinase (Mmp2 and Mmp9) expression and activity in giant cell arteritis lesions
    Segarra, M
    Sánchez, M
    Garcia-Martínez, A
    Lozano, E
    Hernández-Rodríguez, J
    Cid, MC
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S218 - S219
  • [45] Expression of MMP2 and MMP9 (Gelatinases A and B) in Human Colon Cancer Cells
    Damodharan, Umadevi
    Ganesan, Ravikumar
    Radhakrishnan, Uma C.
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2011, 165 (5-6) : 1245 - 1252
  • [46] Matrix metalloproteinases MMP2 and MMP9 are upregulated by noradrenaline in the mouse neuroendocrine hypothalamus
    Maolood, N.
    Hardin-Pouzet, H.
    Grange-Messent, V.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 27 (05) : 1143 - 1152
  • [47] MMP2、MMP9在肾癌中的表达及意义
    李泽良
    刘同才
    孙志熙
    王平
    孔垂泽
    温强
    中国医科大学学报, 2001, (04) : 59 - 60+66
  • [48] Inhibition of MMP2/MMP9 after spinal cord trauma reduces apoptosis
    Dang, Alexis B. C.
    Tay, Bobby K. -B.
    Kim, Hubert T.
    Nauth, Aaron
    Alfonso-Jaume, Maria Alexandra
    Lovett, David H.
    SPINE, 2008, 33 (17) : E576 - E579
  • [49] Activity of MMP2 and MMP9 matrix metalloproteinases in patients with myeloproliferative and lymphoproliferative diseases
    Gordiienko, I. A.
    VISNYK OF DNIPROPETROVSK UNIVERSITY-BIOLOGY MEDICINE, 2014, 5 (01): : 54 - 57
  • [50] Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro
    Lelongt, B
    Trugnan, G
    Murphy, G
    Ronco, PM
    JOURNAL OF CELL BIOLOGY, 1997, 136 (06): : 1363 - 1373